Board of Directors

Peter Ernster
Chairman of the Board of Directors

Ronald H. Goldfarb, Ph.D.
Sopherion Therapeutics, Inc.
Director

Christopher Moller, Ph.D.
TL Ventures
Director

James Niedel, M.D., Ph.D.
New Leaf Venture Partners
Director

Marc J. Ostro, Ph.D.
TL Ventures
Director

Seth A. Rudnick, M.D.
Canaan Partners
Director

Joyce Tsang, Ph.D.
ProQuest Investments
Director

Donald Yarson
Genzyme General
Director


 

 

 

Terms and Conditions
Copyright © Sopherion Inc. All rights reserved.